Fulcrum Therapeutics Inc (FULC)

Dec 19, 2024

Fulcrum Therapeutics (NASDAQ:FULC) shareholders have endured a 77% loss from investing in the stock three years ago - Yahoo Finance

Dec 19, 2024

Dec 18, 2024

Analysts Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) PT at $9.33 - Defense World

Dec 18, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Acquires 393,202 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 17, 2024

Dec 16, 2024

FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm! - The Eastern Progress Online

Dec 16, 2024

Dec 16, 2024

Fulcrum Therapeutics' SWOT analysis: stock faces headwinds after trial setback - Investing.com

Dec 16, 2024

Dec 15, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Dec 15, 2024

Dec 13, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Stock Holdings Trimmed by Fmr LLC - MarketBeat

Dec 13, 2024

Dec 13, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold by Fmr LLC - Defense World

Dec 13, 2024

Dec 12, 2024

Fulcrum Therapeutics Insider Purchases Yet To Pay Off Regardless Of Recent Strength - Simply Wall St

Dec 12, 2024

Dec 10, 2024

Jacobs Levy Equity Management Inc. Takes $721,000 Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 10, 2024

Dec 06, 2024

BlackRock, Inc. Reduces Stake in Fulcrum Therapeutics Inc. - GuruFocus.com

Dec 06, 2024

Dec 05, 2024

Fulcrum Therapeutics' SWOT analysis: stock faces challenges after trial setback - Investing.com Nigeria

Dec 05, 2024

Dec 05, 2024

RA Capital Management L.P. Sells 1,380,605 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Dec 05, 2024

Nov 30, 2024

Braidwell LP Acquires New Stake in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 30, 2024

Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Makes New $474,000 Investment in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 30, 2024

Nov 29, 2024

Fulcrum Therapeutics (FULC) Upgraded to Buy: Here's Why - MSN

Nov 29, 2024

Nov 29, 2024

Suvretta Capital Management LLC Sells 1,358,255 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 29, 2024

Nov 27, 2024

Fulcrum Therapeutics to Participate in Upcoming December Conferences - The Manila Times

Nov 27, 2024

Nov 26, 2024

Fulcrum Therapeutics to Present at Three Major Healthcare Conferences in December | FULC Stock News - StockTitan

Nov 26, 2024

Nov 21, 2024

CAMP4 Therapeutics Corporation (CAMP) reports earnings - Quartz

Nov 21, 2024

Nov 20, 2024

Brokerages Set Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Price Target at $9.33 - MarketBeat

Nov 20, 2024

Nov 19, 2024

Facioscapulohumeral Muscular Dystrophy Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Fulcrum Therapeutics, aTyr Pharma, Fulcrum Therapeutics, Hoffmann-La Roche - The Globe and Mail

Nov 19, 2024

Nov 19, 2024

Fulcrum Therapeutics stock hits 52-week low at $2.87 By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 19, 2024

Fulcrum Therapeutics stock hits 52-week low at $2.87 - Investing.com

Nov 19, 2024

Nov 18, 2024

HC Wainwright Analysts Increase Earnings Estimates for FULC - MarketBeat

Nov 18, 2024

Nov 17, 2024

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2024 Earnings Call Transcript - MSN

Nov 17, 2024

Nov 16, 2024

Fulcrum Therapeutics, Inc. Announces Board Changes - Marketscreener.com

Nov 16, 2024

Nov 15, 2024

Simplify Asset Management Inc. Sells 323,518 Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - MarketBeat

Nov 15, 2024

Nov 15, 2024

Fulcrum Therapeutics Third Quarter 2024 Earnings: US$0.35 loss per share (vs US$0.39 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Fulcrum Therapeutics Inc. (FULC) Tops Q3 EPS by 5c - StreetInsider.com

Nov 14, 2024

Nov 14, 2024

Fulcrum Therapeutics (NASDAQ:FULC) Receives Neutral Rating from HC Wainwright - MarketBeat

Nov 14, 2024

Nov 14, 2024

Expert Ratings For Fulcrum Therapeutics - Benzinga

Nov 14, 2024

Nov 14, 2024

Fulcrum Therapeutics Inc (FULC) Q3 2024 Earnings Call Highlights - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Fulcrum Therapeutics Inc (FULC) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst ... - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

Fulcrum Therapeutics appoints new independent director - Investing.com India

Nov 13, 2024

Nov 13, 2024

Fulcrum Therapeutics appoints new independent director By Investing.com - Investing.com South Africa

Nov 13, 2024

Nov 13, 2024

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024 - The Manila Times

Nov 13, 2024

Nov 13, 2024

Fulcrum Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 12, 2024

Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference - The Manila Times

Nov 12, 2024

Nov 12, 2024

Fulcrum Therapeutics (FULC) to Present at Stifel Healthcare Conference | Investor Update | FULC Stock News - StockTitan

Nov 12, 2024

Nov 07, 2024

Fulcrum Therapeutics (FULC) Scheduled to Post Earnings on Wednesday - MarketBeat

Nov 07, 2024

Nov 06, 2024

Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET - The Manila Times

Nov 06, 2024